Table 1.
Participants | Age (years) | Gender | Years from diagnosis | Clinical state | UPDRS part III | FOG-Q |
---|---|---|---|---|---|---|
PD1 | 61 | Female | 7 | ON | 10 | 0.33 (0.51) |
PD2 | 77 | Male | 6 | OFF | 29 | 0.66 (1.06) |
PD3 | 64 | Female | 2 | ON | 18 | 0.33 (0.52) |
PD4 | 66 | Female | 4 | ON | 37 | 0.5 (0.55) |
PD5 | 50 | Male | 2 | ON | 23 | 0.66 (1.03) |
PD6 | 58 | Male | 7 | ON | 27 | 0.66 (1.03) |
PD7 | 68 | Female | 6 | OFF | 35 | 3.00 (0.63) |
PD8 | 76 | Male | 5 | ON | 28 | 3.16 (0.43) |
PD9 | 59 | Female | 4 | ON | 36 | 2.66 (0.81) |
PD10 | 69 | Male | 6 | OFF | 41 | 3.33 (0.51) |
PD11 | 70 | Female | 10 | ON | 43 | 0.66 (1.06) |
PD12 | 66 | Male | 4 | ON | 37 | 0.5 (0.55) |
The clinical state is related to the effect of the medication: ON, responding well to medication; OFF, not responding to medication.